shortage of tirzepatide Lilly's weight-loss drug removed from FDA's list Compounded Tirzepatide Crisis! Patients Left

Maintaining some level of medication, even at reduced frequency, may help prevent this rebound

Refills are always here when I need it

Patients who respond inadequately to semaglutide alone often benefit from switching to tirzepatidea dual GLP-1 and GIP receptor agonist that activates additional appetite-suppression pathwaysrather than adding a stimulant medication

114, S728S729

H.ValentiL.HuY.-Y.et al (2024)

GLP-1 Support Group Empower your health journey with our next GLP-1 Support Group Our GLP-1 Support Group is designed for individuals who are currently using or preparing to start GLP-1 medications (such as semaglutide and tirzepatide) for weight management and metabolic health